Stefanie Keil

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

J. Tillner, Maximilian Posch, Frank Wagner et al. · Diabetes Obesity and Metabolism · 2018 · 162 citations

Medicine, Pharmacokinetics, Pharmacology +17

Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin Epitope

Stefanie Keil, C. Claus, Wolfgang Dippold et al. · Angewandte Chemie International Edition · 2001 · 122 citations

Medicine, Immunology, Oncology +17

Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study

Stefanie Keil, Karen Anjema, Francjan J. van Spronsen et al. · PEDIATRICS · 2013 · 81 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates

Ralf Elvert, Andreas W. Herling, Martin Bossart et al. · Diabetes Obesity and Metabolism · 2018 · 41 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Identification and Synthesis of Novel Inhibitors of Acetyl-CoA Carboxylase with in Vitro and in Vivo Efficacy on Fat Oxidation

Stefanie Keil, Marco Müller, G. Zöller et al. · Journal of Medicinal Chemistry · 2010 · 26 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17